Collegium Pharma (COLL) Tops Q3 EPS by 29c
Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.